Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Future of High-Tech Healthcare

Over the past two years, the healthcare industry has experienced significant changes in how, when, and where it utilizes technology. In addition, the way patients perceive and want to interact with the healthcare system has undergone a dramatic shift. In this “Health and Life Sciences at the Edge” podcast, host Michelle Mooney talks with Alex…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Over the past two years, the healthcare industry has experienced significant changes in how, when, and where it utilizes technology. In addition, the way patients perceive and want to interact with the healthcare system has undergone a dramatic shift. In this “Health and Life Sciences at the Edge” podcast, host Michelle Mooney talks with Alex Flores, head of Intel’s Global Health Solutions vertical, about the causes and trends driving these changes.  

“I believe three things are behind the changes we’re seeing,” says Flores. “The healthcare industry is moving at pandemic-speed; there’s been an accelerated investment in and adoption of artificial intelligence (AI); and patient expectations have evolved.” 

The pandemic forced healthcare leaders to quickly digitize many aspects of the system so care could be delivered outside the traditional four walls of clinics and hospitals. This increased the adoption AI, with more than 84% of healthcare leaders surveyed saying they expect widespread AI adoption within five years. 

Patients have come to expect healthcare to be more personal, convenient, and flexible. “The resulting ‘hybrid care models’ have created a demand for additional compute, security, data storage, and analysis, particularly in hospitals” says Flores.  

Tech and data-driven hospitals (Smart Hospitals) are employing extensible tech frameworks that enable workflow agility across healthcare partners, providers, and systems. “In today’s digital-first world,” says Flores, “Smart Hospitals are significantly increasing connectivity, intelligence and automation. Ultimately, these lead to improved care models and workflow efficiencies.” 

Intel’s superpowers – AI, ubiquitous computing, pervasive connectivity, edge to cloud infrastructure – are particularly relevant to healthcare due to the sheer amount of data generated by the healthcare system. “It’s estimated that healthcare produced about 30% of the world’s data produced worldwide,” says Flores, “but only 5% of that data gets analyzed.” This points to the need to enable more analytics at the “intelligent edge” in hospitals and clinics.  

Looking to the future, Flores is excited about how digital technologies can revolutionize the healthcare industry. In particular, he points to the concept of the “digital twin,” which allows a comprehensive and predictive model of a patient. to be generated by aggregating and coupling data with real-time information. “The digital-twin can also be applied to physical hospitals and allows stakeholders to review how implementing innovative solutions would impact operational efficiencies.”  

“The bottom line,” says Flores, “is that in order for the healthcare industry to truly transform, it will need to embrace technology and dedicate itself to improving the patient journey.” 

Connect with Alex Flores on LinkedIn 

To learn more about Smart Hospitals, visit Smart Hospital 

Follow @IntelHealth on Twitter  

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Internet of Things Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

MRI segmentation models can now label 80 structures, but deployment is the hard part

MRI segmentation models can now label 80 structures. TotalSegmentator MRI is an nnU-Net model that provides rapid segmentation of all major organs across all MRI sequences, according to Radiology Business. For health systems, deployment is the hard part.

  • 01The spread between 0.97 Dice on lungs and 0.54 on portal and splenic veins in MRSegmentator is the real operational story: enterprises need confidence flags and escalation paths, not a single headline score.
  • 02Hospitals planning radiation oncology and neuro volumetry programs can treat segmentation speedups as capacity gains only if downstream steps, contour review, dose planning inputs, and reporting templates, are standardized.

Sep 8, 2026

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512